# Rigel Pharmaceuticals, Inc. (RIGL): MoatMap facts

As of 28 Oct 2026. Research data, not investment advice.

As of 28 Oct 2026, MoatMap's StockRank for Rigel Pharmaceuticals, Inc. (RIGL) is 98/100, ranked against 24,000+ stocks in 35 markets (Quality 81, Value 69, Momentum 65, each scored against its sector).

- StockRank: 98/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 81, Value 69, Momentum 65: each a 0-100 percentile within Healthcare.
- Position: #463 overall, #48 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 50.55 USD on 27 Oct 2026.
- Insider filings, last 180 days: directors sold USD 160K.
- Buybacks, last 180 days: the company bought back USD 4.3M on 2 days.

Source: https://moatmap.ai/stock/RIGL
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker